Finally, using mice genetically deficient in components of the plasminogen activation system, we have previously shown that the anti-tumor activity of the uPA-activated PA in vivo is dependent on cell surface uPA activity [52], [53], [73], [74], [76]. This evidence concerns the gene PLG and neoplasm.